PMC:7195088 / 32607-32950
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T38 | 91-104 | Body_part | denotes | interleukin 6 | http://purl.org/sig/ont/fma/fma264829 |
| T39 | 91-102 | Body_part | denotes | interleukin | http://purl.org/sig/ont/fma/fma86578 |
| T40 | 127-135 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T169 | 190-198 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T183 | 91-104 | http://purl.obolibrary.org/obo/PR_000001393 | denotes | interleukin 6 |
| T184 | 205-210 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T440 | 14-25 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T441 | 44-55 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T442 | 205-210 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T443 | 308-314 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T262 | 200-249 | Sentence | denotes | Open-label RCT (NCT04322773, not yet recruiting). |
| T263 | 250-343 | Sentence | denotes | Primary endpoint: time to independence from supplementary oxygen therapy (follow-up 28 days). |